Pharma channel feed

#ESC22: Bay­er's fac­tor XIa in­hibitor miss­es ef­fi­ca­cy marks in 2 PhII stud­ies but com­pa­ny dives straight in­to PhI­II

3 years ago
R&D

#ESC22: ‘Anx­ious for more ev­i­dence’: As­traZeneca touts DE­LIV­ER da­ta in bid to ex­pand Farx­i­ga’s heart fail­ure la­bel 

3 years ago
R&D

Gilead fights back against BMS Supreme Court pe­ti­tion in patent fight

3 years ago
Law

In­cyte se­cures sec­ond FDA ap­proval for bile duct can­cer drug in mu­tat­ed can­cer type

3 years ago
FDA+

With two new ex­pen­sive gene ther­a­py ap­provals, out­comes-based pric­ing deals grab the spot­light again

3 years ago
R&D

No­var­tis turns to re­al metasta­t­ic breast can­cer pa­tient for ‘first gen­er­a­tion’ Kisqali TV ad

3 years ago
Marketing

US and Chi­na de­vel­op frame­work for in­spec­tion of 200 US-list­ed com­pa­nies un­der threat of delist­ing

3 years ago
China

A push for trans­paren­cy: US to make all fed­er­al­ly-fund­ed re­search pub­lic

3 years ago

Al­ny­lam draws on pa­tient artist’s strik­ing de­pic­tions of life with a rare ge­net­ic dis­ease in new ad cam­paign

3 years ago
Marketing

Chi­na and US con­sid­er pos­si­ble so­lu­tion for US-list­ed com­pa­nies in vi­o­la­tion of new law — re­port

3 years ago

Pfiz­er teams with his­tor­i­cal­ly Black uni­ver­si­ty for new vac­cine pub­lic health doc­tor­ate pro­gram

3 years ago
Marketing

In­ovio agrees to shell out $44M to set­tle Covid-19 vac­cine law­suit

3 years ago
Coronavirus
Law

US con­sid­ers use of ex­pired mon­key­pox vac­cines amid ris­ing de­mand for dos­es

3 years ago

Ab­b­Vie re-ups so­cial and dig­i­tal cor­po­rate cam­paign star­ring re­al pa­tients and em­ploy­ees

3 years ago
Marketing

Klick Health opens in-house pro­duc­tion stu­dio, along with new brand­ing and in­flu­encer busi­ness­es

3 years ago
Marketing

PACT Phar­ma sus­pends sole clin­i­cal tri­al

3 years ago
People

In­ter­change­abil­i­ty with­out switch­ing stud­ies: FDA ex­plains why a new Lu­cen­tis biosim­i­lar may be a game-chang­er

3 years ago
FDA+

Ex-Kad­mon con­sul­tant faces up to 20 years in prison fol­low­ing guilty plea over in­sid­er trad­ing

3 years ago
Law

Why does the FDA se­lect cer­tain drugs for ad­comm meet­ings? Re­searchers want to know

3 years ago
FDA+

In­di­v­ior fails to es­cape class ac­tion law­suit in Sub­ox­one case

3 years ago
Law

Mor­ton Grove Phar­ma­ceu­ti­cals to dis­con­tin­ue op­er­a­tions at Illi­nois site due to on­go­ing man­u­fac­tur­ing is­sues

3 years ago
Manufacturing

So much to say, so lit­tle space. FDA-led stud­ies as­sess risk in­for­ma­tion on so­cial me­dia

3 years ago
FDA+
Marketing

Mar­ket­ingRx roundup: Pfiz­er press­es Comir­naty case for teens in new com­mer­cial; Idor­sia de­buts Olympic ski­er ad

3 years ago
Marketing

Q&A: GSK vac­cine leader Judy Stew­art nav­i­gates vac­ci­na­tion slumps, al­ways-on mar­ket­ing and in­no­vat­ing da­ta tools

3 years ago
Marketing
First page Previous page 177178179180181182183 Next page Last page
A service from the Financial Times